It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The new device is for people with an irreversible, advanced form of macular degeneration in which a blind spot develops in the central vision of both eyes. The telescope replaces the eye’s nature lens and can provide an image that is magnified by almost three times. The device then magnifies and projects the images onto a healthy portion of the retina. It can only be used in one eye because the other is needed for peripheral vision.
The firm behind the telescope claims that it will help patients suffering from end-stage age-related macular degeneration (AMD), a disease which is the leading cause of vision loss in the US.
The firm behind the telescope, VisionCare, must now carry out two further studies, following up existing patients and beginning a study of 770 new patients. Each telescope will cost $15,000.